Skip to content

Author

M. Wiedenmann

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Clesrovimab, a monoclonal antibody for the prevention of respiratory syncytial virus disease in infants: a drug profile.

INTRODUCTION Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection (LRTI) in young children. In children < 5 years old, it causes an estimated 33 million LRTI episodes and over 100,000 deaths annually, two-thirds of which occur in infants. The licensure of new long-acting monoc...

M. Wiedenmann, Z. Dangor, S. Madhi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.